Evidence map›Paper›PMID 34212557›Full record

ArticleCroatian medical journal2021

Clinical and pathohistological characteristics of Alport spectrum disorder caused by COL4A4 mutation c.193-2A>C: a case series.

Petar Šenjug, Tamara Nikuševa Martić, Marija Šenjug Perica, Maja Oroz, Matija Horaček, Kristina Gotovac Jerčić, Krešimir Galešić, Danica Galešić Ljubanović

Open access · diamondAbstract read
In one paragraph

Article in Croatian medical journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Petar Šenjug
Tamara Nikuševa MartićTamara Nikuševa Martić, Department of Biology, Zagreb University School of Medicine, Šalata 3, 10000 Zagreb, Croatia, tamara.nikuseva.martic@mef.hr.
Marija Šenjug Perica
Maja Oroz
Matija Horaček
Kristina Gotovac Jerčić
Krešimir Galešić
Danica Galešić Ljubanović
University of Zagreb · HRUniversity Hospital Centre Zagreb · HRUniversity Hospital Dubrava · HRChildren's Hospital Srebrnjak · HRUniversity Hospital for Infectious Diseases "Dr Fran Mihaljevic" · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo present the pathohistological and clinical characteristics of five Croatian families with Alport spectrum disorders caused by splice acceptor pathogenic variant c.193-2A>C in COL4A4 at the genomic position chr2:227985866.

methodsThe study enrolled five probands with kidney biopsy analysis and five family members. Mutation screening was performed with Illumina MiSeq platform. The pathogenic variant was confirmed with standard dye-terminator sequencing.

resultsThe only homozygous patient, aged two, had proteinuria and hematuria with preserved kidney function and no extrarenal manifestations. This patient had changes characteristic for Alport syndrome observed on electron microscopy of the kidney biopsy. In the heterozygous group, six patients had hematuria, four biopsied probands had proteinuria, and only one had moderately reduced kidney function. Heterozygous probands had variable kidney biopsy findings. Three patients had thin glomerular basement membrane nephropathy visible on electron microscopy and focal segmental glomerulosclerosis on light microscopy, two of them with focal lamellation on electron microscopy. One heterozygous patient had changes characteristic for Alport syndrome on electron microscopy without focal segmental glomerulosclerosis.

conclusionThe homozygous patient had hematuria and proteinuria with preserved kidney function. The heterozygous patients presented with reasonably mild clinical phenotype and variable pathohistological findings.

Indexed as

Collagen Type IVNephritis, HereditaryHematuriaHumansMutationPedigreeCOL4A4 protein, humanCollagen Type IV

Identifiers

PMID34212557
PMCPMC8275942
OpenAlexW3174664662

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.